Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H14O2 |
| Molecular Weight | 238.2812 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OCC1=CC=CC=C1)\C=C\C2=CC=CC=C2
InChI
InChIKey=NGHOLYJTSCBCGC-VAWYXSNFSA-N
InChI=1S/C16H14O2/c17-16(12-11-14-7-3-1-4-8-14)18-13-15-9-5-2-6-10-15/h1-12H,13H2/b12-11+
| Molecular Formula | C16H14O2 |
| Molecular Weight | 238.2812 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
8 % single, topical Highest studied dose Dose: 8 % Route: topical Route: single Dose: 8 % Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Irritation skin... Other AEs: Irritation skin (3.2%) Sources: |
1 mL 1 times / day multiple, intramuscular Highest studied dose Dose: 1 mL, 1 times / day Route: intramuscular Route: multiple Dose: 1 mL, 1 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: F Food Status: UNKNOWN Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Irritation skin | 3.2% | 8 % single, topical Highest studied dose Dose: 8 % Route: topical Route: single Dose: 8 % Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Benzyl cinnamate (Jacobson's solution) with vitamin A. A one-year experience in the treatment of cerebrovascular lesions. | 1960-03 |
|
| Cerebrovascular accidents; a clinical evaluation of treatment with a solution of benzyl cinnamate (Jacobson's solution) with vitamin A. | 1958-12 |
|
| Vascular changes in diabetic and arteriolosclerotic retinopathy obtained by a modified solution of benzyl cinnamate. | 1953-04-15 |
|
| Mode of action of benzyl cinnamate solution in chronic inflammatory lesions of the pelvis. | 1951-08 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20252991
Unknown
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:31 GMT 2025
by
admin
on
Mon Mar 31 17:55:31 GMT 2025
|
| Record UNII |
V67O3RO97U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION |
SCCS/1459/11
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
||
|
JECFA EVALUATION |
BENZYL CINNAMATE
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB13024MIG
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
V67O3RO97U
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
DTXSID3041663
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
557
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
11780
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
1649557
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
103-41-3
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
44403
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
100000087378
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
203-109-3
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
Benzyl cinnamate
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
m2403
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
V67O3RO97U
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
C526327
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
359
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
5273469
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
PRIMARY | |||
|
78277-23-3
Created by
admin on Mon Mar 31 17:55:31 GMT 2025 , Edited by admin on Mon Mar 31 17:55:31 GMT 2025
|
ALTERNATIVE |